Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by qwerty22


T.TH

RE:RE:RE:RE:On the positive side

"fully recruit within the original timeline" What is that...

October 13, 2022

T.TH

RE:RE:RE:RE:RE:RE:Expectations too high. Reset your animus.

There's something called Intention to treat, look it up. You don't...

October 13, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Poster on Sortilin expression based on microarray

Anyway that's me moaning about other people moaning. Let's hope...

October 12, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Poster on Sortilin expression based on microarray

The negative reaction on this board to this PR. It's not the efficacy...

October 12, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Poster on Sortilin expression based on microarray

It's really not understandable. They aren't all expected to twiddle...

October 12, 2022

T.TH

RE:Poster on Sortilin expression based on microarray

The science is so thin on Sortilin in cancer that every little helps...

October 12, 2022

T.TH

RE:RE:RE:Poster on Sortilin expression based on microarray

  ABOUT THE SYMPOSIUM ENA 2022 is the drug...

October 12, 2022

T.TH

RE:RE:RE:RE:RE:RE:“Low dose docetaxel”

The paper I linked to was for palliative patients who had been through...

October 11, 2022

T.TH

RE:RE:“Low dose docetaxel”

I generally agree with your sentiment but I don't know exactly what you...

October 11, 2022

T.TH

RE:RE:RE:RE:“Low dose docetaxel”

They'll never get to test this on newly diagnosed patients. Imagine the...

October 11, 2022

T.TH

RE:RE:“Low dose docetaxel”

We don't have zilch, we have uncertainty. We have a problem of assigning...

October 11, 2022

V.FL

RE:Great results but

They've been talking about fielding lots of phone calls. Let's say...

October 11, 2022

T.TH

“Low dose docetaxel”

So I went back to an idea I had when the 1a info was released regarding the...

October 11, 2022

V.RHT.H

RE:RE:here are revenues estimates for next 3 Qs based on

ATM longs, shorts and traders are getting no joy from this stock. On that...

October 11, 2022

V.FL

RE:PHASE 1 : Premium spodumene concentrate

Written as a neat paragraph it sounds easy as. I'm going to ask the same...

October 11, 2022

V.FL

RE:RE:RE:RE:326 meters averaging 1.9 percent!!

I'm concerned this Q is going to be rough for the wider bear market. Is...

October 11, 2022

V.FL

RE:RE:326 meters averaging 1.9 percent!!

Delay on the PFS to Q1/23

October 11, 2022

T.TH

RE:RE:RE:RE:RE:RE:Strategies for the drug discovery...

Presumably if it's generating responders now then it'll generate...

October 10, 2022

T.TH

RE:RE:RE:RE:RE:RE:Recent study

I meant to add, it all depends on how good the drug is performing, but maybe...

October 10, 2022

T.TH

RE:RE:RE:RE:RE:Recent study

https://www.biocurate.com/resources/proof-of-concept-industrys-perspective/ ...

October 10, 2022

Featured Company